Funding · Healthcare & Life Sciences

4baseCare raises ₹90 crore in Series B

By Startup Enthusiast · 27 January 2026

What they do

4baseCare is a precision oncology company that integrates genomic testing with clinical data

It raised ₹90 crore in a Series B round co-led by Ashish Kacholia and Lashit Sanghvi

The funds will expand its genomics lab network and develop AI-based clinical decision tools

4baseCare announced the first close of its Series B funding round.
The company raised ₹90 crore (approximately $9.8 million).
The round was co-led by Ashish Kacholia and Lashit Sanghvi.
Existing investor Yali Capital also participated in the round.
The company plans to use the funds to expand its hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia.
It will also accelerate development of AI-based clinical decision support solutions, including OncoTwin Insights.
OncoTwin Insights helps oncologists derive treatment insights from clinico-genomic and outcomes-linked datasets.
The company's OncoTwin was selected for the MSK iHub programme of Memorial Sloan Kettering Cancer Centre in New York.

The healthtech market is projected to grow at 39% CAGR from 2025 and exceed $37 billion by 2030.
About $700 million was raised by healthtech startups in 2025.
This round comes after a gap of two years since the Series A in 2024.
The company also received a grant from the Karnataka government in 2024.

4baseCare is a precision oncology company that builds population-relevant clinico-genomic intelligence.
It integrates genomic testing with real-world clinical and outcomes data to provide actionable insights.
The company works with hospitals to offer genomics-led cancer diagnostics in clinical settings.
Its product OncoTwin Insights helps oncologists derive treatment insights from clinico-genomic and outcomes-linked datasets.
The company was selected for the MSK iHub programme of Memorial Sloan Kettering Cancer Centre.

Expand hospital-linked genomics lab network across India, Middle East, Southeast Asia, Latin America, and Central Asia.
Accelerate development and deployment of AI-based clinical decision support solutions, including OncoTwin Insights.

Product: Genomics-based cancer diagnostic tests and OncoTwin, an AI clinical decision support platform.
Customers: Oncologists, cancer patients, and hospital networks.
How it makes money: Fees for diagnostic testing services and software-driven clinical decision insights.
What sets it apart: Combines clinico-genomic and real-world lifestyle data tailored for underrepresented populations.
Operations: Operates genomics laboratories and partners with hospital networks across emerging markets.